HD Korea Shipbuilding & Offshore Engineering Co., Ltd. (KRX:009540)
South Korea · Delayed Price · Currency is KRW 343,000
-16,000 (-4.46%)
At close: Aug 1, 2025, 3:30 PM KST
Verve Therapeutics Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 27,964,773 | 26,549,542 | 22,129,416 | 18,085,469 | 15,503,989 | 14,908,712 | Upgrade |
Other Revenue | -1,170,116 | -1,010,965 | -833,210 | -783,449 | -10,607 | -5,054 | Upgrade |
| 26,794,657 | 25,538,577 | 21,296,206 | 17,302,020 | 15,493,382 | 14,903,658 | Upgrade | |
Revenue Growth (YoY) | 21.96% | 19.92% | 23.09% | 11.67% | 3.96% | -1.84% | Upgrade |
Cost of Revenue | 23,396,215 | 22,951,481 | 20,255,285 | 16,944,142 | 16,016,025 | 14,166,898 | Upgrade |
Gross Profit | 3,398,442 | 2,587,096 | 1,040,920 | 357,879 | -522,643 | 736,760 | Upgrade |
Selling, General & Admin | 1,026,063 | 976,744 | 641,309 | 653,249 | 646,043 | 541,584 | Upgrade |
Research & Development | 122,218 | 115,410 | 98,003 | 81,845 | 80,777 | 74,538 | Upgrade |
Other Operating Expenses | 8,032 | 7,979 | 7,252 | 6,708 | 7,249 | 8,320 | Upgrade |
Operating Expenses | 1,278,036 | 1,162,772 | 759,727 | 710,835 | 866,487 | 663,194 | Upgrade |
Operating Income | 2,120,406 | 1,424,324 | 281,193 | -352,957 | -1,389,130 | 73,566 | Upgrade |
Interest Expense | -185,953 | -206,322 | -193,879 | -165,846 | -177,732 | -208,877 | Upgrade |
Interest & Investment Income | 217,986 | 216,706 | 207,998 | 137,205 | 63,481 | 63,047 | Upgrade |
Earnings From Equity Investments | 535.2 | 5,921 | 78.97 | -5,676 | -10,579 | 136.22 | Upgrade |
Currency Exchange Gain (Loss) | 536,723 | 858,478 | 49,408 | 170,940 | 231,599 | -152,476 | Upgrade |
Other Non Operating Income (Expenses) | -320,442 | -460,013 | -308,253 | -157,447 | -404,203 | -139,989 | Upgrade |
EBT Excluding Unusual Items | 2,369,256 | 1,839,094 | 36,545 | -373,780 | -1,686,563 | -364,593 | Upgrade |
Gain (Loss) on Sale of Investments | 1,668 | 2,351 | -3,177 | -31,771 | -1,583 | 8,514 | Upgrade |
Gain (Loss) on Sale of Assets | 15,141 | -5,417 | 5,889 | 5,901 | 80,569 | 62,693 | Upgrade |
Asset Writedown | -13,365 | -13,365 | -47,303 | -31,445 | -24,607 | -275,582 | Upgrade |
Pretax Income | 2,372,700 | 1,822,663 | -8,046 | -431,095 | -1,632,184 | -568,968 | Upgrade |
Income Tax Expense | 499,840 | 368,083 | -152,976 | -135,918 | -490,980 | 266,210 | Upgrade |
Earnings From Continuing Operations | 1,872,860 | 1,454,580 | 144,930 | -295,177 | -1,141,204 | -835,178 | Upgrade |
Net Income to Company | 1,872,860 | 1,454,580 | 144,930 | -295,177 | -1,141,204 | -835,178 | Upgrade |
Minority Interest in Earnings | -394,073 | -282,244 | 76,781 | 78,227 | 211,885 | 1,391 | Upgrade |
Net Income | 1,478,786 | 1,172,336 | 221,711 | -216,950 | -929,319 | -833,787 | Upgrade |
Net Income to Common | 1,478,786 | 1,172,336 | 221,711 | -216,950 | -929,319 | -833,787 | Upgrade |
Net Income Growth | 168.65% | 428.77% | - | - | - | - | Upgrade |
Shares Outstanding (Basic) | 71 | 71 | 71 | 71 | 71 | 71 | Upgrade |
Shares Outstanding (Diluted) | 71 | 71 | 71 | 71 | 71 | 71 | Upgrade |
EPS (Basic) | 20912.03 | 16578.41 | 3135.29 | -3067.96 | -13141.82 | -11790.87 | Upgrade |
EPS (Diluted) | 20912.03 | 16578.41 | 3135.29 | -3067.96 | -13141.82 | -11790.87 | Upgrade |
EPS Growth | 168.65% | 428.77% | - | - | - | - | Upgrade |
Free Cash Flow | 4,705,936 | 3,397,582 | 1,259,638 | -204,645 | 452,855 | -468,424 | Upgrade |
Free Cash Flow Per Share | 66548.26 | 48046.38 | 17812.97 | -2893.96 | 6403.97 | -6624.14 | Upgrade |
Gross Margin | 12.68% | 10.13% | 4.89% | 2.07% | -3.37% | 4.94% | Upgrade |
Operating Margin | 7.91% | 5.58% | 1.32% | -2.04% | -8.97% | 0.49% | Upgrade |
Profit Margin | 5.52% | 4.59% | 1.04% | -1.25% | -6.00% | -5.59% | Upgrade |
Free Cash Flow Margin | 17.56% | 13.30% | 5.92% | -1.18% | 2.92% | -3.14% | Upgrade |
EBITDA | 2,662,119 | 1,950,097 | 753,137 | 68,219 | -990,397 | 482,729 | Upgrade |
EBITDA Margin | 9.93% | 7.64% | 3.54% | 0.39% | -6.39% | 3.24% | Upgrade |
D&A For EBITDA | 541,713 | 525,773 | 471,944 | 421,176 | 398,733 | 409,163 | Upgrade |
EBIT | 2,120,406 | 1,424,324 | 281,193 | -352,957 | -1,389,130 | 73,566 | Upgrade |
EBIT Margin | 7.91% | 5.58% | 1.32% | -2.04% | -8.97% | 0.49% | Upgrade |
Effective Tax Rate | 21.07% | 20.20% | - | - | - | - | Upgrade |
Advertising Expenses | - | 10,044 | 11,949 | 8,890 | 7,762 | 1,938 | Upgrade |
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.